The Effect of Stimulant Treatment for ADHD on Later Substance Abuse and the Potential for Medication Misuse, Abuse, and Diversion

Brain foods: The effects of nutrients on brain function.

Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372 · see citing works

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928 · see citing works

Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues

Zhao, R., Matherly, L. H., & Goldman, I. D. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000969 · Cited by 391 · see citing works

Stimulant <scp>ADHD</scp> medication and risk for substance abuse

Chang, Z., Lichtenstein, P., Halldner, L., D'Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12164 · Cited by 225 · see citing works

Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies

Fredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.016 · Cited by 173 · see citing works

The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies

Young, S., Adamou, M., Bolea-Alamanac, B. M., Gudjonsson, G. H., Müller, U., Pitts, M. E., Thome, J., & Asherson, P. J. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-32 · Cited by 169 · see citing works

Unmet Need for Mental Health Care in Schizophrenia: An Overview of Literature and New Data From a First-Admission Study

Mojtabai, R., Fochtmann, L. J., Chang, S.-W., Kotov, R., Craig, T., & Bromet, E. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp045 · Cited by 159 · see citing works

The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?

Kaye, S. S., & Darke, S. G. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03720.x · Cited by 136 · see citing works

An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use

Gudjonsson, G. H., Sigurðsson, J. F., Sigfúsdóttir, I. D., & Young, S. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02489.x · Cited by 118 · see citing works

The CATIE and CUtLASS Studies in Schizophrenia

Naber, D., & Lambert, M. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00002 · Cited by 105 · see citing works

A Placebo‐Controlled Trial of Atomoxetine in Marijuana‐Dependent Individuals with Attention Deficit Hyperactivity Disorder

McRae‐Clark, A. L., Carter, R. E., Killeen, T. K., Carpenter, M. J., White, K., & Brady, K. T. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00076.x · Cited by 90 · see citing works

Lisdexamfetamine Dimesylate: Linear Dose‐Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open‐Label Single‐Dose Pharmacokinetic Study in Healthy Adult Volunteers

Ermer, J., Homolka, R., Martin, P., Buckwalter, M., Purkayastha, J., & Roesch, B. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009357346 · Cited by 72 · see citing works

Misuse of Prescription and Illicit Drugs among High-Risk Young Adults in Los Angeles and New York

Lankenau, S. E., Schrager, S. M., Silva, K., Kecojevic, A., Bloom, J. J., Wong, C. F., & Iverson, E. (2012) · Journal of Public Health Research · doi:10.4081/jphr.2012.e6 · Cited by 71 · see citing works

Diagnosing and treating attention‐deficit/hyperactivity disorder in adults

Faraone, S. V., & Antshel, K. M. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00179.x · Cited by 66 · see citing works

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

Montoya, A. G., Amaia Hervas, G., Cardo, E., Artigas-Pallarés, J., Mardomingo, M. J., Alda, J. A., Gastaminza, X., García-Polavieja, M. J., Gilaberte, I., & Escobar, R. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903316152 · Cited by 64 · see citing works

Nutrient-Based Therapies for Bipolar Disorder: A Systematic Review

Sylvia, L., Peters, A., Deckersbach, T., & Nierenberg, A. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000341309 · Cited by 51 · see citing works

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD

Bain, E., Robieson, W., Pritchett, Y., Garimella, T. S., Abi‐Saab, W., Apostol, G., McGough, J. J., & Saltarelli, M. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.194 · Cited by 55 · see citing works

Medicinal Effect of Nutraceutical Fruits for the Cognition and Brain Health

Keservani, R. K., Sharma, A. K., & Kesharwani, R. K. (2016) · Scientifica · doi:10.1155/2016/3109254 · Cited by 55 · see citing works

Shared Decision Making in Antipsychotic Management

Mistler, L. A., & Drake, R. E. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000341889.97759.54 · Cited by 48 · see citing works

Attention‐ D eficit/ H yperactivity D isorder, P hysical H ealth, and L ifestyle in O lder A dults

Semeijn, E. J., Kooij, J. J. S., Comijs, H. C., Michielsen, M., Deeg, D. J. H., & Beekman, A. T. F. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12261 · Cited by 48 · see citing works

Issues in the Diagnosis and Treatment of Adult ADHD by Primary Care Physicians

Adler, L. A., Shaw, D. M., Sitt, D. J., Maya, E., & Morrill, M. I. (2009) · Primary psychiatry · Cited by 46 · see citing works

Ethical issues in psychopharmacology of children and adolescents

Kölch, M. G., Schnoor, K., & Fegert, J. M. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328314b776 · Cited by 43 · see citing works

Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder

Wei, Y. J., Zhu, Y., Liu, W., Bussing, R., & Winterstein, A. G. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1152 · Cited by 40 · see citing works

Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions

Mattingly, G. W., Wilson, J. A., Ugarte, L., & Glaser, P. E. A. (2020) · CNS Spectrums · doi:10.1017/s1092852919001822 · Cited by 40 · see citing works

Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives

Daubner, J., Arshaad, M. I., Henseler, C., Hescheler, J., Ehninger, D., Broich, K., Rawashdeh, O., Papazoglou, A., & Weiergräber, M. (2021) · Journal of Neural Transplantation and Plasticity · doi:10.1155/2021/8823383 · Cited by 35 · see citing works

The implications of Methylphenidate use by healthy medical students and doctors in South Africa

Beyer, C., Staunton, C., & Moodley, K. (2014) · BMC Medical Ethics · doi:10.1186/1472-6939-15-20 · Cited by 36 · see citing works

Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).

Sánchez-Mora, C., Ramos-Quiroga, J., Garcia-Martínez, I., Fernàndez-Castillo, N., Bosch, R., Richarte, V., Palomar, G., Nogueira, M., Corrales, M., Daigre, C., et al. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.002 · Cited by 33 · see citing works

The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder

Perugi, G., & Vannucchi, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1079620 · Cited by 38 · see citing works

Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders

Spencer, A. E., Valentine, S. E., Sikov, J., Yule, A. M., Hsu, H., Hallett, E., Xuan, Z., Silverstein, M., & Fortuna, L. (2021) · Pediatrics · doi:10.1542/peds.2020-023523f · Cited by 34 · see citing works

Prospective relationships of ADHD symptoms with developing substance use in a population-derived sample

Sihvola, E., Rose, R. J., Dick, D. M., Korhonen, T., Pulkkinen, L., Raevuori, A., MARTTUNEN, M. J., & Kaprio, J. A. (2011) · Psychological Medicine · doi:10.1017/s0033291711000791 · Cited by 34 · see citing works

Cognitive Behavioral Treatment Outcomes in Adolescent ADHD

Antshel, K. M., Faraone, S. V., & Gordon, M. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.3.334 · Cited by 33 · see citing works

Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder

Faraone, S. V. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.9.1565 · Cited by 33 · see citing works

Background, clinical features and treatment of attention deficit hyperactivity disorder in children

Warikoo, N., & Faraone, S. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.818977 · Cited by 34 · see citing works

Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder

Steer, C., Froelich, J., Soutullo, C. A., Johnson, M., & Shaw, M. (2012) · CNS Drugs · doi:10.2165/11634340-000000000-00000 · Cited by 30 · see citing works

Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey

Şahpolat, M., & Arı, M. (2020) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2020.1815080 · Cited by 30 · see citing works

Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

Heal, D. J., & Smith, S. L. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211032475 · Cited by 30 · see citing works

The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia

Canever, L., Alves, C. S. V., Mastella, G. A., Damázio, L. S., Polla, J. V., Citadin, S. A., Luca, L. A. D., Barcellos, A. S., Garcez, M. L., Quevedo, J., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0493-7 · Cited by 28 · see citing works

Trait aggression, depression and suicidal behavior in drug dependent patients with and without ADHD symptoms

Bácskai, E., Czobor, P., & Gerevich, J. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.06.005 · Cited by 27 · see citing works

Antipsychotic medication, mortality and neurodegeneration: The need for more selective use and lower doses

Weinmann, S., & Aderhold, V. (2009) · Psychosis · doi:10.1080/17522430903501999 · Cited by 27 · see citing works

Influence of the MTHFR C677T Polymorphism on Magnetic Resonance Imaging Hyperintensity Volume and Cognition in Geriatric Depression

Hong, E. D., Taylor, W. D., McQuoid, D. R., Potter, G. G., Payne, M. E., Ashley‐Koch, A. E., & Steffens, D. C. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181aad5b2 · Cited by 27 · see citing works

Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults

Nogueira, M., Bosch, R., Valero, S., Gómez-Barros, N., Gloria Palomar, A., Vanesa Richarte, B., Montse Corrales, F., Nasillo, V., Vidal, R., Casas, M., et al. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.12.002 · Cited by 25 · see citing works

A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder

Ghanizadeh, A. J. (2014) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2014.972975 · Cited by 22 · see citing works

Folate-modified Graphene Oxide as the Drug Delivery System to Load Temozolomide

Wang, L.-H., Liu, J., Sui, L., Zhao, P., Ma, H.-D., Wei, Z., & Wang, Y. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200226122742 · Cited by 21 · see citing works

Safety of stimulant treatment in attention deficit hyperactivity disorder: part II

Merkel, R. L. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.503238 · Cited by 21 · see citing works

Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents

Bello, N. T. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s73167 · Cited by 21 · see citing works

Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment

Mischoulon, D., Lamon‐Fava, S., Selhub, J., Katz, J., Papakostas, G. I., Iosifescu, D. V., Yeung, A., Dording, C. M., Farabaugh, A. H., Clain, A. J., et al. (2012) · CNS Spectrums · doi:10.1017/s1092852912000430 · Cited by 20 · see citing works

Safety of stimulant treatment in attention deficit hyperactivity disorder: part I

Merkel, R. L., & Kuchibhatla, A. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903279956 · Cited by 24 · see citing works

Serum folate, vitamin B12and cognitive impairment in Chilean older adults

Castillo-Lancellotti, C., Margozzini, P., Valdivia, G. G., Padilla, O., Uauy, R. D., Rozowski, J., & Tur, J. A. (2015) · Public Health Nutrition · doi:10.1017/s1368980014003206 · Cited by 20 · see citing works

Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management

O’Connor, L., Carbone, S., Gobbo, A., Gamble, H., & Faraone, S. V. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2249414 · Cited by 19 · see citing works

Epidemiology of Attention Deficit Hyperactivity Disorder

Faraone, S. V. (2011) · Wiley eBooks · doi:10.1002/9780470976739.ch25 · Cited by 19 · see citing works

Efficacy of Metadoxine Extended Release in Patients With Predominantly Inattentive Subtype Attention-Deficit/Hyperactivity Disorder

Manor, I., Newcorn, J. H., Faraone, S. V., Adler, L. A., & The Metadoxine Study Group (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2689 · Cited by 17 · see citing works

Attention-deficit/hyperactivity disorder in persistent criminal offenders: the need for specialist treatment programs

Young, S., & Goodwin, E. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.142 · Cited by 17 · see citing works

Treatment of Aggressive ADHD in Children and Adolescents: Conceptualization and Treatment of Comorbid Behavior Disorders

McBurnett, K., & Pfiffner, L. J. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.11.2084 · Cited by 18 · see citing works

The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study

Brynte, C., Aeschlimann, M., Barta, C., Begeman, A., Bäcker, A., Crunelle, C., Daigre, C., de Fuentes-Merillas, L., Demetrovics, Z., Dom, G., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04259-6 · Cited by 15 · see citing works

Designing outcome studies to determine efficacy and safety of antipsychotics for ‘real world’ treatment of schizophrenia

Altamura, A. C., & Glick, I. D. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991271 · Cited by 16 · see citing works

The association of psychiatric symptomatology with patterns of alcohol, tobacco, and marijuana use among Brazilian high school students

Fidalgo, T. M., Sanchez, Z. M., Caetano, S. C., Maia, L. O., Carlini, E. A., & Martins, S. S. (2016) · American Journal on Addictions · doi:10.1111/ajad.12407 · Cited by 16 · see citing works

Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder

Marusich, J. A., McCuddy, W. T., Beckmann, J. S., Gipson, C. D., & Bardo, M. T. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32834d623e · Cited by 15 · see citing works

Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities

Scott, D. A., Gignac, M., Kronfli, R. N., Ocana, A., & Lorberg, G. W. (2015) · Journal of Correctional Health Care · doi:10.1177/1078345815618392 · Cited by 14 · see citing works

Three Effective Ways to Nurture Our Brain

Misuraca, R., Miceli, S., & Teuscher, U. (2017) · European Psychologist · doi:10.1027/1016-9040/a000284 · Cited by 14 · see citing works

Novel Formulations of ADHD Medications: Stimulant Selection and Management

Childress, A. C. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200032 · Cited by 13 · see citing works

Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications

Jain, R., & Stark, J. G. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1218259 · Cited by 12 · see citing works

Prevalence of Adult Attention Deficit Hyperactivity Disorder and its Correlates among Recently Diagnosed Young Adult Males with HIV

Kumar, S. (2014) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000314 · Cited by 13 · see citing works

The Benefits and Limitations of Stimulants in Treating ADHD

Coghill, D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_331 · Cited by 11 · see citing works

TDAH et comorbidités en pédopsychiatrie. Pathologies psychiatriques, affections médicales, troubles de l’apprentissage et de la coordination

Masi, L., & Gignac, M. (2016) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2015.11.013 · Cited by 10 · see citing works

Home-Based Patient-Delivered Remotely Supervised Transcranial Direct Current Stimulation

Knotkova, H., Clayton, A. M., Stevens, M., Riggs, A., Charvet, L., & Bikson, M. (2019) · Practical Guide to Transcranial Direct Current Stimulation · doi:10.1007/978-3-319-95948-1_13 · Cited by 6 · see citing works

Trends in Attention-Deficit Hyperactivity Disorder Diagnosis and Pharmacotherapy Among Adults With Opioid Use Disorder

Park, T. W., Baul, T. D., Morgan, J. R., Wilens, T. E., & Yule, A. M. (2023) · Psychiatric Services · doi:10.1176/appi.ps.20220400 · Cited by 9 · see citing works

Early-life risperidone enhances locomotor responses to amphetamine during adulthood

Stubbeman, B. L., Brown, C. J., Yates, J. R., & Bardgett, M. E. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.025 · Cited by 9 · see citing works

OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder

McBurnett, K., & Starr, H. L. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.546058 · Cited by 8 · see citing works

Methylphenidate use among students living in junior on-campus residences of the University of the Free State

Zyl, P. M. V., Joubert, G., Fechter, L., Griesel, J., Nel, M., Honiball, A., Serfontein, L., & Diedericks, M. (2017) · South African Family Practice · doi:10.1080/20786190.2017.1292695 · Cited by 8 · see citing works

Oral Methylphenidate Treatment of an Adolescent ADHD Rat Model Does Not Alter Cocaine-Conditioned Place Preference during Adulthood: A Negative Report

Zhang‐James, Y., Lloyd, D. R., James, M. L., Yang, L., Richards, J. B., & Faraone, S. V. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190021 · Cited by 8 · see citing works

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder

Scherrer, J. F., Salas, J., Grucza, R., Wilens, T., Quinn, P. D., Sullivan, M. D., Rossom, R., Wright, E. A., Piper, B., Sanchez, K., et al. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100122 · Cited by 7 · see citing works

Epigenetics as a link between environmental factors and dementia risk

Koulouri, A., & Zannas, A. S. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241284227 · Cited by 6 · see citing works

Stimulant Use Disorder Diagnoses in Adolescent and Young Adult Medicaid Enrollees

Bushnell, G., Keyes, K. M., Zhu, Y., Cerdá, M., Gerhard, T., Hasin, D. S., Iizuka, A., Lloyd, K., Samples, H., & Olfson, M. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2864 · Cited by 6 · see citing works

An online survey of Turkish psychiatrists’ attitudes about and experiences of adult attention deficit hyperactivity disorder in clinical practice

Altın, M., Altın, G. E., & Semerci, B. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s110720 · Cited by 3 · see citing works

Attention-Deficit Hyperactivity Disorder

Meletis, C. D., & Zabriskie, N. (2008) · Alternative and Complementary Therapies · doi:10.1089/act.2008.14501 · Cited by 6 · see citing works

Adult Attention Deficit Disorder and Aggressive Behaviour: An Exploration of Relationships between Brown Attention-Deficit Disorder Scales and the Aggression Questionnaire

Byrne, M. K., Parletta, N., Webster, D., Batterham, M. J., & Meyer, B. J. (2014) · Psychiatry Psychology and Law · doi:10.1080/13218719.2014.960027 · Cited by 5 · see citing works

Assessment of ADHD

Weyandt, L. L., & DuPaul, G. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5345-1_4 · Cited by 4 · see citing works

A comprehensive evaluation of adverse childhood experiences, social–emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practice

Trovini, G., Amici, E., Bauco, P., Matrone, M., Lombardozzi, G., Giovanetti, V., Kotzalidis, G. D., & Filippis, S. D. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2436 · Cited by 4 · see citing works

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study

Więckiewicz, G., Stokłosa, I., Stokłosa, M., Więckiewicz, W., Gorczyca, P. W., & Gondek, T. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1184023 · Cited by 3 · see citing works

Diagnostic Assessment

Kooij, J. J. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4138-9_2 · Cited by 3 · see citing works

18 Nutrition and Mental Health

Galil, N., & Hedaya, R. (2017) · CRC Press eBooks · doi:10.1201/9781315100913-19 · Cited by 3 · see citing works

The Clinical Effects of School Group Sandplay Therapy (SGST) on Anxiety/Depression, Somatic Symptoms, Social Immaturity, and Rule-Breaking Behavior in Children at Risk for ADHD

Han, H.-S., Yi, Y.-S., Lee, M.-B., Shin, H.-Y., Lee, Y. I., Lee, C. M., Lee, Y. L., & Lim, M. H. (2025) · Children · doi:10.3390/children12121592 · Cited by 2 · see citing works

Methylphenidate use among students living in junior on-campus residences of the University of the Free State

Zyl, P. M. V., Joubert, G., Fechter, L., Griesel, J., Nel, M., Honiball, A., Serfontein, L., & Diedericks, M. (2017) · South African Family Practice · doi:10.4102/safp.v59i4.4736 · Cited by 2 · see citing works

Management of attention deficit/hyperactivity disorder and the use of stimulants in prison. Evaluation of the risks and benefits

Fructuoso, A. (2019) · Revista Española de Sanidad Penitenciaria · doi:10.4321/s1575-06202019000200008 · Cited by 2 · see citing works

Treatment

Kooij, J. J. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82812-7_4 · Cited by 2 · see citing works

Pharmacotherapy

Weyandt, L. L., & DuPaul, G. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5345-1_6 · Cited by 2 · see citing works

Stimulants in Bipolar Depression: Risks and Benefits

Núñez, N. A., Salgado, M. F., & Frye, M. A. (2023) · Psychiatric Annals · doi:10.3928/00485713-20230201-01 · Cited by 2 · see citing works

Risk Factors Associated With Incident Opioid Prescription Among Attention-Deficit/Hyperactivity Disorder Patients Prescribed Stimulants

Shrestha, M., Okeke, C. M., Shen, C., Kang, D. W., LESLIE, D. L., Varisco, T. J., Olateju, O. A., Wanat, M. A., & Thornton, J. D. (2026) · Annals of Pharmacotherapy · doi:10.1177/10600280251413628 · Cited by 2 · see citing works

Future Directions for Practice and Research

Weyandt, L. L., & DuPaul, G. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5345-1_7 · Cited by 1 · see citing works

A Young Man with History of ADHD and Methamphetamine Use

Leikauf, J. E., & Ivanov, I. (2013) · Psychiatric Annals · doi:10.3928/00485713-20130109-06 · Cited by 1 · see citing works

Nutrition and Mental Health

Galil, N., & Hedaya, R. (2017) · CRC Press eBooks · doi:10.1201/b22342-18 · Cited by 1 · see citing works

ADHD and Substance Use

Chadi, N., Green, L., & Schizer, M. (2020) · ADHD in Adolescents · doi:10.1007/978-3-030-62393-7_14

Management of Attention Deficit/Hyperactivity Disorder (ADHD) with Methylphenidate - A Brief Review

Singh, G. (2021) · Eastern Journal of Psychiatry · doi:10.5005/ejp-14-1--2-1 · Cited by 1 · see citing works

Treatment

Kooij, J. J. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4138-9_4 · Cited by 1 · see citing works

ADHD in Adolescents (Middle and High School)

Weyandt, L. L., & DuPaul, G. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5345-1_2 · Cited by 1 · see citing works

Diagnostics

Kooij, J. J. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82812-7_2 · Cited by 1 · see citing works

Attention deficit hyperactivity disorder

Lazar, S. M., & Voigt, R. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824060-1.00017-1 · Cited by 1 · see citing works

Developmental Disorders of Attention

Cohen, R. A. (2013) · Springer eBooks · doi:10.1007/978-0-387-72639-7_18 · Cited by 1 · see citing works

A perspective on nutritional genomics.

Escott-Stump, S. (2009) · Topics in Clinical Nutrition · doi:10.1097/tin.0b013e3181a6b8f5

Diagnosis and Treatment Issues In Adult ADHD

Adler, L. A., & Gasbarro, R. D. (2009)

Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.

Faraone, S., & Wilens, T. (2007) · PubMed · Cited by 75 · see citing works

ADHD and substance misuse in young people: from cutting edge research to the coal face reality of clinical practice

Mirza, K. A. H., Sudesh, R. M., & Mirza, S. (2012) · Cutting Edge Psychiatry in Practice · doi:10.65031/tnqh2400

The abuse potential of medications for attention-deficit/hyperactivity disorder: Recent advances in our understanding

Ghaffari, M. (2009) · Current Attention Disorders Reports · doi:10.1007/s12618-009-0005-4 · Cited by 5 · see citing works

ADHD, Substance Use Disorders, and Psychostimulant Treatment: Current Literature and Treatment Guidelines

Kollins, S. H. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707311654 · Cited by 136 · see citing works

Substance abuse in patients with attention-deficit/hyperactivity disorder.

Bukstein, O. G. (2008) · PubMed Central · Cited by 27 · see citing works